[Atherosclerosis. Congress of the European Atherosclerosis Society (EAS), Athens (Greece), 26-29 May 1999].
Constans
J
J
Service de médecine interne et pathologie vasculaire, hôpital Saint-André, Bordeaux.
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000378:metabolism; D001161:Arteriosclerosis / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D001205:Ascorbic Acid / Q000627:therapeutic use; D008078:Cholesterol, LDL / Q000378:metabolism; D004032:Diet; D005060:Europe; D005492:Folic Acid / Q000627:therapeutic use; D006115:Greece; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications; D008074:Lipoproteins / Q000378:metabolism; D017035:Pravastatin / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D012307:Risk Factors; D012955:Societies, Medical; D014280:Triglycerides / Q000378:metabolism
D000924:Anticholesteremic Agents; D000975:Antioxidants; D008078:Cholesterol, LDL; D008074:Lipoproteins; D014280:Triglycerides; D005492:Folic Acid; D011736:Pyridoxine; D017035:Pravastatin; D001205:Ascorbic Acid